H.C. Wainwright (Rodman & Renshaw) Starts Second Sight Medical (EYES) at Buy
Tweet
Share
E-mailGet Alerts EYES Hot Sheet
Price: $30.20 -0.63%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
H.C. Wainwright (Rodman & Renshaw) initiated coverage on Second Sight Medical (NASDAQ: EYES) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Second Sight Medical click here. For more ratings news on Second Sight Medical click here.
Shares of Second Sight Medical closed at $14.05 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- JPMorgan Resumes SanDisk (SNDK) at Overweight
- UBS Starts Schrodinger (SDGR) at Neutral
Create E-mail Alert Related Categories
Hot New Coverage, Momentum Movers, New CoverageRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
